Home > Healthcare > Medical Devices > Therapeutic Devices > Neuromuscular Electric Stimulator Market

Neuromuscular Electric Stimulator Market Trends

  • Report ID: GMI11802
  • Published Date: Oct 2024
  • Report Format: PDF

Neuromuscular Electric Stimulator Market Trends

The growing demand for non-invasive treatment options is a significant driver for the market. NMES devices, which deliver electrical impulses to stimulate muscle contractions, are increasingly favoured due to their ability to provide effective treatment without the risks and recovery time associated with surgical interventions.
 

  • Patients and healthcare providers are increasingly opting for NMES as an alternative to pharmaceuticals, particularly in pain management and muscle rehabilitation, where traditional drug therapies may pose risks of dependency or adverse side effects.
     
  • The American Physical Therapy Association (APTA) notes that NMES is a well-validated method for enhancing muscle strength and promoting functional recovery, particularly in patients who cannot engage in conventional exercise due to injury or surgery. For example, NMES devices are widely used in sports medicine to facilitate recovery from injuries, improve muscle strength, and prevent muscle atrophy in immobilized patients. A study published in the Journal of Orthopaedic & Sports Physical Therapy highlighted that NMES therapy significantly reduced recovery time and improved muscle function in athletes recovering from anterior cruciate ligament (ACL) reconstruction.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global neuromuscular electric stimulator industry was valued at USD 381.7 million in 2023 and is expected to grow at a 9.1% CAGR from 2024 to 2032, driven by technological advancements and increasing demand for rehabilitation solutions.

The handheld neuromuscular stimulators segment generated USD 309.8 million in 2023, favored for their convenience and ease of use compared to bulky stationary devices.

North America neuromuscular electric stimulator industry recorded USD 157.3 million in 2023 and is anticipated to grow at an 8.4% CAGR from 2024 to 2032, supported by a well-established healthcare infrastructure and increasing incidence of musculoskeletal disorders.

Key players in the industry include AxioBionics LLC, Enovis Corporation, Ibramed Medical, MTR + Vertriebs GmbH, NeuroMetrix, Inc., OMRON Corporation, Ottobock, RS Medical, Sky Medical Technology Ltd., and Verity Medical Ltd.

Neuromuscular Electric Stimulator Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 150
  • Countries covered: 23
  • Pages: 134
 Download Free Sample